These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21074812)

  • 1. Editorial comment.
    Akhtar NH; Tagawa ST
    J Urol; 2011 Jan; 185(1):59. PubMed ID: 21074812
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Singer EA; Srinivasan R; Bratslavsky G
    J Urol; 2011 Jan; 185(1):66. PubMed ID: 21074200
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
    J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive nephrectomy for metastatic renal cell carcinoma.
    McKiernan J; Wood CG
    J Urol; 2013 Aug; 190(2):386-8. PubMed ID: 23702308
    [No Abstract]   [Full Text] [Related]  

  • 5. For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
    Aron M; Gill IS
    J Urol; 2009 Sep; 182(3):832-3. PubMed ID: 19643447
    [No Abstract]   [Full Text] [Related]  

  • 6. Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
    Carver BS
    J Urol; 2009 Sep; 182(3):833-4. PubMed ID: 19616224
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Klatte T
    J Urol; 2009 Dec; 182(6):2606. PubMed ID: 19836796
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment.
    Shichman SJ
    Urology; 2010 Feb; 75(2):281. PubMed ID: 20152480
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Lane BR; Campbell SC
    Urology; 2010 Feb; 75(2):281. PubMed ID: 20152479
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy.
    Chowdhury S; Harper PG; Choueiri TK
    Nat Clin Pract Oncol; 2008 Dec; 5(12):698-9. PubMed ID: 18852722
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment.
    Uzzo RG
    J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastatic renal cell carcinoma: recent advances in the targeted therapy era.
    Di Lorenzo G; Autorino R; Sternberg CN
    Eur Urol; 2009 Dec; 56(6):959-71. PubMed ID: 19748725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment to effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.
    Gudbjartsson T
    Int J Urol; 2013 Jun; 20(6):579. PubMed ID: 23621609
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment on: Results of endoluminal occlusion of the inferior vena cava during radical nephrectomy and thrombectomy.
    Kirkali Z
    Eur Urol; 2008 Oct; 54(4):783-4. PubMed ID: 18524465
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 18. Node positive renal cell cancer. Who can be helped?
    Messing EM
    Eur Urol; 2007 Jun; 51(6):1477-8. PubMed ID: 17240037
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Capitanio et al.: Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (Urology 2008;72:1090-1095).
    Chung SD; Chu SH; Tsai CC
    Urology; 2009 Mar; 73(3):682-3; author reply 683-4. PubMed ID: 19248907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.